Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02300584 · ClinicalTrials.gov registry record · NA

Distance Savvy: Testing Tele-Savvy, a Distance Dementia Family Caregiver Education Program

A NA study of Depression and Dementia, sponsored by Emory University.

Completed
Registry status
NA
Development phase
42
Enrollment target
1
Study location

NCT02300584: Completed NA study of Depression and Dementia, sponsored by Emory University.

NCT02300584 is a NA study of Depression and Dementia that has completed, run by Emory University. The registered enrollment target is 42 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02300584, a NA study of Depression and Dementia, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
42 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to refine and test the web-based delivery of a well-established in-person group program that provides information and education to informal caregivers (family and friends) of persons with Alzheimer's disease (or related illnesses).

Interventions

  • BEHAVIORAL Tele-Savvy
  • OTHER iPad

Study Locations (1)

Georgia

  • Emory Alzheimer's Disease Research Center - Atlanta

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2014-11
Est. Completion 2015-10
Phase NA
Emory University

1,208 total trials

What the finished NCT02300584 record still lists

NCT02300584 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (95% lower).

The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Tele-Savvy is the first listed.

NCT02300584 reports a single indexed study location in Georgia.

Frequently Asked Questions

What is clinical trial NCT02300584 about?

NCT02300584 is a clinical study titled "Distance Savvy: Testing Tele-Savvy, a Distance Dementia Family Caregiver Education Program". The purpose of this study is to refine and test the web-based delivery of a well-established in-person group program that provides information and education to informal caregivers (family and friends) of persons with Alzheimer's disease (or related illnesses).

What is the current status of trial NCT02300584?

This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2014-11. Estimated completion is 2015-10.

What conditions does trial NCT02300584 study?

This clinical trial studies the following conditions: Depression, Dementia, Alzheimers Disease.

What interventions are being tested in trial NCT02300584?

The interventions under investigation include: Tele-Savvy (BEHAVIORAL), iPad (OTHER).

Who is sponsoring clinical trial NCT02300584?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02300584 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02300584's enrollment target sits among peer trials

42 501st of 679 higher than 175 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02852213 · 42 participants · Phase 1

    A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients

  • NCT03136146 · 42 participants · Phase 2

    Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

  • NCT03178149 · 42 participants · Phase 1

    A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

  • NCT03663530 · 42 participants · NA

    Circadian Misalignment and Energy Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02300584, the US trial registry maintained by the National Library of Medicine. NCT02300584 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.